ストックスクリーナーアプリを入手
13.88
0.64%
-0.09
Amarin Corp Adr (AMRN) 最新ニュース
Amarin Corporation Plc Sponsored ADR Revenue Breakdown – LSX:A41557 - TradingView
Amarin Corporation Plc Sponsored ADR Revenue Breakdown – FWB:EH3 - TradingView
Amarin CorpADR (AMRN) Fundamental & Financial Data - Stocktwits
AMRN: Amarin CorpADR Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bears are Losing Control Over Amarin (AMRN), Here's Why It's a 'Buy' Now - Yahoo Finance
EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma - TradingView
AMRNAmarin Corp ADR Options - Finviz
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why - TradingView
Amarin Corporation Plc Sponsored ADR Actuals & Estimates (NASDAQ:AMRN) - TradingView
EH3 Forecast — Price Target — Prediction for 2027 - TradingView
Here's Why You Should Add ANIX Stock to Your Portfolio Now - TradingView
Reasons Why Investors Should Consider Betting on Indivior Stock - TradingView
Net income before discontinued operations of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Price to book ratio of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Non-operating income (total) of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Current ratio of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Free cash flow per share of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Diluted earnings per share (diluted EPS) of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView
Amarin Corporation Plc Sponsored ADR Revenue Breakdown – DUS:EH3 - TradingView
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma - Benzinga
AMRN Technical Analysis | Trend, Signals & Chart Patterns | AMARIN CORP PLC -ADR (NASDAQ:AMRN) - ChartMill
Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Amarin shareholders reject key proposals at annual meeting, limit equity grants - Investing.com
CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised - TradingView
Amarin (NASDAQ: AMRN) investors curb new share issues and limit equity pay tools - Stock Titan
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales - TradingView
All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy - Yahoo Finance
Amarin (AMRN) Loss Trend Of 24.2% Annually Tests Turnaround Narratives Heading Into Q1 - Sahm
Amarin (NASDAQ:AMRN) Surprises with Revenue Beat but EPS Falls Short Amid Restructuring Costs - ChartMill
ChannelStock ScreenerCharts - Finviz
Amarin Corp PLC (FRA:EH3) Stock Price, Trades & News - GuruFocus
Amarin Corporation Plc Sponsored ADR Trade Ideas — FWB:EH3 - TradingView
Will Amarin (AMRN) Stock Go Higher | Price at $14.77, Up 0.20%Hot Stock Picks - The Legal Advocate
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz
Amarin Corporation Plc Sponsored ADR Trade Ideas — SWB:EH3 - TradingView
Amarin (NASDAQ: AMRN) details VASCEPA reach, Recordati deal and $70M savings - Stock Titan
Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss - Finviz
Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 - ChartMill
BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Ex-Amarin CEO Loses Suit Over Ouster After Proxy Fight - Law360
Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance
Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Finviz
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance
Which stocks are gapping on Tuesday? - ChartMill
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Finviz
RCKT Stock Tanks on Patient Death in Danon Disease Study - Barchart.com
CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies - Finviz
Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigat - GuruFocus
Global X Aging Population ETF Holdings - Quiver Quantitative
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Top movers in Wednesday's session - ChartMill
Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees - 24/7 Wall St.
What is the current Price Target and Forecast for Amarin (AMRN) - Zacks Investment Research
Which stocks have an unusual volume on Friday? - ChartMill
Which stocks are gapping on Wednesday? - ChartMill
Tuesday's session: gap up and gap down stocks - ChartMill
1.79%
0.61%
大文字化:
|
ボリューム (24 時間):